FDA Inspection, understand FDA,implementing FDA, e 2012 - Live web confrence on FDA Inspections Preparation and Management By compliance2go
Date2012-08-29
Deadline2012-08-29
VenueHouston, USA - United States
KeywordsFDA’s Part 11,enforcing 21 CFR 11,advantage,cost-effective,risk-based Part 11,21 CFR 11,risk management,suppliers,validation,
Topics/Call fo Papers
Why should you Attend :
Who want to understand FDA inspection, and maybe involve FDA inspections in the future?
Description of the event:
For everyone involved, FDA inspections are time consuming and labour intensive processes, but they need not be frustrating or mysterious if a company has prepared properly. The most important preparation is complying with the pertinent laws and regulations, including developing and implementing an effective quality system. The webinar helps you preparing and managing FDA inspections.
Webinar Includes:
Q/A Session with the Expert to ask your question
PDF print only copy of PowerPoint slides
60 Minutes Live Presentation
Areas Covered in the seminar:
Introduce background information for FDA inspections
Describe FDA inspection procedure
Analyses inspection outcomes
Provide insight into elements that should be considered in developing a response.
Who will benefit: (Titles)
Everybody who may involve FDA inspections.
Executive/senior management
Regulatory management
QA management
Any personnel who may have direct interaction with FDA officials
Consultants
Quality system auditors
All Regulatory Professionals
About Speaker
Dr. Linda Yang, was until recently Associate Director, Regulatory Affairs for a pharmaceutical company. Currently as an independent consultant, she provides directions for regulatory strategy, regulatory submission, clinical studies, CMC requirements for different development stages, product indications, and labelling.
She has spent last 19 years working for pharmaceutical companies and is an expert in regulatory and quality compliance. She has broad background and played leadership role in functional areas such as product development, business process optimization, quality compliance, clinical development, and regulatory strategy. She had hands on experience on global regulatory management and submission. She has experience working with US, European and other global regulatory regulations. She co-authored the book of the Fundamentals of US Regulatory Affairs (2009).
Dr. Yang currently teaches regulatory affairs and compliance for University of Berkeley Extension, and regulatory and pharmaceutical development for Pharmaceutical Training Institute (PTI).
Dr. Yang obtained her Ph.D in 1992; MBA in 2004; Certifications of Regulatory Affairs (RAC) and Quality Auditor (CQA) in 2009.
Who want to understand FDA inspection, and maybe involve FDA inspections in the future?
Description of the event:
For everyone involved, FDA inspections are time consuming and labour intensive processes, but they need not be frustrating or mysterious if a company has prepared properly. The most important preparation is complying with the pertinent laws and regulations, including developing and implementing an effective quality system. The webinar helps you preparing and managing FDA inspections.
Webinar Includes:
Q/A Session with the Expert to ask your question
PDF print only copy of PowerPoint slides
60 Minutes Live Presentation
Areas Covered in the seminar:
Introduce background information for FDA inspections
Describe FDA inspection procedure
Analyses inspection outcomes
Provide insight into elements that should be considered in developing a response.
Who will benefit: (Titles)
Everybody who may involve FDA inspections.
Executive/senior management
Regulatory management
QA management
Any personnel who may have direct interaction with FDA officials
Consultants
Quality system auditors
All Regulatory Professionals
About Speaker
Dr. Linda Yang, was until recently Associate Director, Regulatory Affairs for a pharmaceutical company. Currently as an independent consultant, she provides directions for regulatory strategy, regulatory submission, clinical studies, CMC requirements for different development stages, product indications, and labelling.
She has spent last 19 years working for pharmaceutical companies and is an expert in regulatory and quality compliance. She has broad background and played leadership role in functional areas such as product development, business process optimization, quality compliance, clinical development, and regulatory strategy. She had hands on experience on global regulatory management and submission. She has experience working with US, European and other global regulatory regulations. She co-authored the book of the Fundamentals of US Regulatory Affairs (2009).
Dr. Yang currently teaches regulatory affairs and compliance for University of Berkeley Extension, and regulatory and pharmaceutical development for Pharmaceutical Training Institute (PTI).
Dr. Yang obtained her Ph.D in 1992; MBA in 2004; Certifications of Regulatory Affairs (RAC) and Quality Auditor (CQA) in 2009.
Other CFPs
- Live web confrence on SOP and FDA Compliance By compliance2go
- Live web confrence on Harmonized Tariff Schedule Classification By Compliance2go
- Live web confrence on China: Compliance Processes for Life Science Products (Company Establishment, Clinical Trials, Registrations, Renewals and Supply Chain Considerations By compliance2go
- Live webinar on Understanding FDA Expectations for Reusable Medical Devices By compliance2go
- Live web confrence on US, EU and Japan GMP Requirements: Practical ICH Area Differences, Healthcare Authority Inspection Focus By compliance2go
Last modified: 2012-07-12 15:09:20